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Abstract
Background: Stationary phase survival proteins (Sps) were found in Firmicutes as having analogous domain
compositions, and in some cases genome context, as the resuscitation promoting factors of Actinobacteria, but
with a different putative peptidoglycan cleaving domain.
Results: The first structure of a Firmicute Sps protein YuiC from B. subtilis, is found to be a stripped down version of the
cell-wall peptidoglycan hydrolase MltA. The YuiC structures are of a domain swapped dimer, although some monomer
is also found in solution. The protein crystallised in the presence of pentasaccharide shows a 1,6-anhydrodisaccharide
sugar product, indicating that YuiC cleaves the sugar backbone to form an anhydro product at least on lengthy
incubation during crystallisation.
Conclusions: The structural simplification of MltA in Sps proteins is analogous to that of the resuscitation
promoting factor domains of Actinobacteria, which are stripped down versions of lysozyme and soluble lytic
transglycosylase proteins.
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Background
Firmicutes, and in particular Bacillus subtilis, form
spores, through a complex and well-studied differenti-
ation to a very stable endospore, where they can survive
for decades until revived; for a recent review see [1]. Fir-
micutes include the genera Bacillus and Clostridia,
which include the pathogenic agents of anthrax, tetanus
and botulism, as well as one of the best-studied labora-
tory bacteria B. subtilis. In contrast in Actinobacteria the
dormant state is the most stable form, where the bac-
teria enter a state of very low metabolic turnover and no
cell division from which they are hard to revive [2]. The
Actinobacteria Mycobacterium tuberculosis (Mtb) sur-
vives in granulomas in the lung for decades in the dor-
mant state. This can be recapitulated in vitro by
extended growth of stationary cultures or by hypoxia [3].
The physiological situations where Firmicutes enter and
exit a dormant state, or at least a late stationary phase
state rather than undergo sporulation, are less well under-
stood in terms of the pathogenic lifecycle than dormancy
in Actinobacteria. However, a dormant state in Firmicutes
can be recapitulated in the laboratory [4, 5]. This paper
describes the first structure of a group of peptidoglycan
cleaving enzymes from Firmicutes, called stationary phase
survival proteins (Sps), that are involved in survival in the
stationary phase and are analogous to the resuscitation
promoting factors (Rpfs) from Actinobacteria.
Resucitation promoting factors revive Actinobacteria
from dormancy [6]. They have a conserved catalytic do-
main that cleaves peptidoglycan [7, 8] and structurally re-
sembles a stripped-down version of lysozyme and lytic
transglycosylases [7, 9]. They vary in the ancillary domains
attached to the catalytic domain. Two models have been
proposed for the action of Rpfs, either they release a pep-
tidoglycan fragment that acts as a signal for a receptor or
the hydrolysis of the peptidoglycan leads to a physical re-
moval of a block to cell division [2, 10–12]. Recent evi-
dence supports the peptidoglycan fragment model [13].
Stationary Phase Survival (Sps) proteins were discovered
by comparison of the domain structure of M.tuberculosis
RpfB with proteins from bacteria in the Firmicute phylum.
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This search found a protein, YabE in B. subtilis, which had
the same ancillary domains (DUF348 × 5-G5-hydrolase)
[14]. This led to the proposal of a non-orthologous domain
displacement event where the overall ancillary domain
architecture of RpfB, and the homology of surrounding
genes, was maintained but the Rpf catalytic domain was re-
placed by another domain widely found in Firmicutes,
which was named ‘stationary phase survival’ (Sps) domain
[14]. The Sps domain has low, but significant, sequence
similarity to the C-terminal region of MltA (membrane-
bound lytic transglycosylase A), which contains the 3D
(three aspartate) domain motif, that includes the catalytic
aspartate, and is consequently a putative peptidoglycan
hydrolase of the MltA/3D family [14].
There are five major groups of Sps proteins in Firmi-
cutes based on their domain structure [14]. The SpsA
group, which includes the B.subtilis protein YocH, con-
tains two LysM domains as well as the Sps domain.
LysM domains bind peptidoglycan and are found in a
range of proteins including some Rpf proteins, amongst
which is the first Rpf to be discovered from M.luteus [6].
SpsB group are the proteins that resemble RpfB in ancil-
lary domain structure. YuiC is a member of the SpsC
group which, like RpfC [15], RpfD and RpfE, only has a
signal peptide and short extensions beyond the con-
served catalytic domain. The SpsD group contains a
COG3883 domain, only found in putative peptidoglycan
cleaving enzymes in Firmicutes, in addition to the catalytic
domain. There is no example of this group in B.subtilis,
nor of the SpsE group that contain two SH3b domains,
again found in peptidoglycan cleaving enzymes, as well as
the catalytic domain. B.subtilis does have a fourth Sps pro-
tein YorM located on a phage in the chromosome, which
are classed in a minor group [14].
Ravagnani et al. [14] proposed that the Sps proteins
were not involved in spore formation and germination,
but in the prolonged survival of these bacteria in station-
ary phase prior to spore formation. Studies have looked
at the effect of deleting the archetypal Sps from B. subti-
lis, YocH [4], and deleting both Sps proteins in Listeria
monocytogenes [16]. Shah and Dworkin [4] showed the
YocH was induced by muropeptides, via the Ser/Thr
kinase PrkC, was active in degrading peptidoglycan in a
zymogram and that deletion of YocH compromised sur-
vival in stationary phase, which could be rescued by
other bacteria secreting YocH. However, YocH is only
one of three genomic Sps proteins in B. subtilis (with a
further Sps protein on a phage carried in many strains).
Pinto et al. [17] showed that knockouts of the Sps pro-
teins in L. monocytogenes extend the lag phase for
growth on minimal medium, but have no effect on rate
or duration of growth in the exponential phase. Recently
a dormant state was shown in the pathogenic Firmicute,
Staphylococcus aureus, that could be revived by culture
supernatant, analogous to the behaviour of Actinobac-
teria. However, the paper did not directly show that an
Sps protein was the active factor [5].
In this paper we present three high-resolution crystal
structures of YuiC, an Sps protein from B. subtilis. These
are of the apo-enzyme (Apo), of the enzyme with a mono-
saccharide, N-acetylglucosamine (NAG) bound in part of
the active site (+NAG) and with a 1,6-anhydro-N-acetyl-
glucosmaine-N-acetylglucosmaine disaccharide product
(+Anhydro) arising from incubation of the enzyme with
penta-N-acetyl-penta-glucosamine (penta-NAG). This de-
fines for the first time the boundaries of the Sps domain
and confirms that it is a minimal catalytically active ver-
sion of the MltA structure. This structural simplicity is
analogous to that of the Rpf domain being a minimal ver-
sion of the Slt/lysozyme fold.
Results and discussion
Protein expression and structure solution
B. subtilis YuiC 32–218 (Uniprot J7JYQ4_BACIU),
which lacks only the predicted signal peptide, was puri-
fied after cytosolic expression in E. coli. This protein ran as
two peaks on gel filtration corresponding to probable
monomer and dimer fractions based on the elution volume
(Additional file 1: Figure S1). The sample also showed par-
tial proteolysis to give a lower molecular weight band on
SDS-PAGE (Additional file 1: Figure S2). Peptide mapping
by mass spectrometry indicated that this was likely to be
cleavage at or close to R52 based on the sequence found in
the Uniprot database. NMR spectroscopy of the truncated
fragment indicated that there was loss of a series of sharp
peaks in the amide region compared to a full-length sam-
ple, consistent with loss of an unstructured region at the
N-terminus (Additional file 1: Figure S3). Subsequent N-
terminal truncated constructs (P73-E218 and P73-K217),
designed to remove the disordered regions of the protein,
still ran with two peaks on gel filtration. So far only the
first-eluting gel filtration (dimer) peak ever produced crys-
tals of any construct.
Three structures of YuiC have been solved by molecular
replacement based on distant homology to E. coli MltA
(see Experimental Procedures). Two are in space group R3
with two chains forming a tight dimer in the asymmetric
unit. Both structures contain ligands bound to both chains.
One contains the partial substrate N-acetylglucosamine
(+NAG) (PDB 4WJT). The other (+anhydro) was grown in
the presence of penta-NAG (PDB 4WLK), but with clear
density in each chain for a 1,6-anhydro-N-acetylglucosa-
mine-1,4-N-acetylglucosamine disaccharide; the expected
product of cleavage of a NAG oligosaccharide substrate.
The other structure has no ligand and was solved in space
group C2221 with a single chain in the asymmetric unit
(Apo) (PDB 4WLI). The apo structure forms a similar
dimer to that seen in the R3 structure (in this case with the
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dimeric symmetry axis corresponding to the crystallo-
graphic two fold axis parallel to the unit cell b axis). Details
of the data collection and refinement are given in Table 1.
Fold analysis
The overall fold of each domain of the symmetric dimer
consists of a mixed direction six stranded double psi
beta barrel surround by five helices (Fig. 1a). In all the
structures, the final two helices and the last strand of
the beta barrel of each half are supplied by the other
chain in the dimer. This appears to be a classical ex-
ample of crystallographic (sub)domain swapping as de-
fined by Eisenberg [17]. It is likely, and certainly
topologically possible, that in the monomeric form seen
in solution the last strand (β6) and final helices (α4 and
α5) of the domain are provided by the same chain.
These three secondary structural elements then swap to
form a dimer at higher protein concentrations (Fig. 1a).
The domain swapping is probably enabled by the abil-
ity of G176 to adopt the necessary phi-psi angles to
allow either monomer or dimer to form. G176 lies at the
end of the third helix. The CAs of G176 in the two
chains are only 4.34 Å apart (Fig. 1a), so movement of a
single helix to an “average” position in the monomer is
plausible. Most of the dimer interface interactions would
be found in a monomer, the exceptions are the interface
between the two copies of the third helix (residues 166–
178). Taking just the residues 166–178 from the two
chains of + NAG using PISA [18] 316 Å2 is buried be-
tween the two helices and surrounding linkers with no
additional hydrogen bonds or salt bridges definitely
formed in the dimer compared to two separate mono-
mers. This compares to 3955 Å2 in the total interface
between the A and B chains. Two hydrogen bonds are
formed from residues in this swapping region to other
parts of the second chain. E166 side chain forms a
hydrogen bond to T 215 very close to C-terminus of the
other chain, and would presumably maintain this link in
the monomer. The hydroxyl of Y172 forms a hydrogen
bond to Glu98 in the other chain. It would take a move-
ment of about 5 Å, rotating the helix in the right direc-
tion to bring G176 to the position of G176 in the other
chain, for this to be an intrachain rather than an inter-
chain hydrogen bond. This indicates that the dimer
should only be slightly more stable than the monomer.
The two ligand bound structures have good electron
density for all residues, and superimpose very well with
a RMSD 0.40 Å over 289 CA atoms of the dimer or
0.23 Å over 145 CA atoms of the pseudo monomer
(formed by chain A 72–176 and chain B 177–216)
(Fig. 1b). The apo structure is locally less ordered than
the substrate bound structures, lacking density for resi-
dues 97–100 and for four residues at the C-terminus
compared to the + NAG structure, which just misses one
residue at the C-terminus. Otherwise, the apo form of
the pseudo monomer superposes well onto the + NAG
structure with an RMSD of 1.15 Å over 135 CA atoms
for the pseudo monomer. The domain swapped dimers
superimpose less well with the RMSD for the apo dimer
vs + NAG of 2.81 Å over 241 CA atoms as a conse-
quence of flexibility in the positioning of the pseudo
monomers within the dimer. The domain swapped
dimer corresponds to a two-fold axis parallel to the third
helix which lies at the centre of the dimer interface. In
the apo crystals, the two fold axis is crystallographic.
If one pair of pseudo monomers is superimposed be-
tween apo and + NAG, it requires a rotation of 26° and a
translation of 6 Å along a screw axis perpendicular to
the third helix to superimpose the second pair of mono-
mers (Fig. 1b) starts at residue 167 just before the third
helix, however the two residues with very large phi/psi
angle changes between liganded and apo structures,
where most of the movement arises are G176 (phi/psi +
NAG −83/−25 apo −77/169) and K178 (phi/psi + NAG
−139/135 apo −88/−40). The flexibility of G176 agrees
with, but does not prove, our proposal that a major re-
arrangement at this residue will generate the non-
domain swapped monomer. The NZ of K178 in the apo
structure forms hydrogen bonds to both the main chain
and side chain carbonyls of N173, whereas in the
liganded structures this side chain is pointing in to solv-
ent. Whether this is the cause of the phi/psi angle at this
residue is not clear. The region 176–178 lies away from
the sugar binding site, so the change is not a direct re-
sult of ligand binding. However the other end of the
third helix lies quite close to the ligand binding site and
the loop that becomes ordered on ligand binding, so the
difference in domain position may be propagated from
sugar binding. However, it is also possible that changes
in crystal packing may be the sole cause of the differ-
ence in the position of the second monomer seen in the
apo structure.
Comparison to MltA
MltA (membrane bound lytic transglycosylase A) (PDB
2ae0) [19] is defined as a single domain in SCOP, but as
two domains in CATH - (2.40.40.10) the Barwin-like
endoglucanase beta barrel, formed by a section from the
N terminus (residues 20–104) (strands β1-3) and the C
terminal region (243–337) (strands β10-14), and an un-
classified domain (105–242). MltA superimposes on the
YuiC (+NAG) structure with an RMSD of 2.07 Å over
102 of the 146 modelled residues (72–217) in the pseudo
monomer (Fig. 1c). This is entirely within the beta barrel
domain of MltA, which is 180 residues long and is
slightly longer than the ordered region of YuiC (146 resi-
dues). Overall YuiC resembles closely the Barwin-like
endoglucanase beta barrel of MltA, but instead of the
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Table 1 Data collection and refinement statistics
Crystal +NAG (truncated K32-E218) Apo (P73-E218) +anhydro (R52-K217)
PDB CODE 4WJT 4WLI 4WLK
Data collection
Wavelength (Å) 0.9795 0.9200 0.9795
Space group R3:H (146) (Hexagonal Cell) C2221 (20) R3:H (146) (Hexagonal Cell)
Cell dimensions
a, b, c (Å) 145.5, 145.5, 37.8 50.0, 117.3, 61.0 147.2, 147.2, 37.9
α, β, γ (°) 90, 90, 120 90, 90, 90 90, 90, 120
Resolution (Å)a 36.37–1.21 (1.23–1.21) 30.8–1.76 (1.79–1.76) 42.50–2.03 (2.08–2.03)
Total number of reflections a 290513 (14071) 132867 (7892) 74023 (5113)
Number of unique reflections a 89967 (4420) 18150 (1026) 19631 (1439)
Rmerge
a 0.043 (0.569) 0.098 (0.745) 0.122 (0.576)
Rmeas
a 0.060 (0.792) 0.114 (0.860) 0.162 (0.764)
Rpim
a 0.041 (0.549) 0.057 (0.425) 0.106 (0.497)
CC (1/2) a 0.998 (0.607) 0.998 (0.771) 0.983 (0.620)
Solvent content (%) 45.7 53.3 44.0
Molecule/asymmetric unit 2 1 2
Wilson B-factor (Å2) 14.4 17.3 21.4
I/σI a 10.3 (2.4) 13 (2.5) 7.5 (2.2)
Completeness (%)a 98.8 (97.2) 99.8 (99.6) 99.4 (98.7)
Redundancy a 3.2 (3.2) 7.3 (7.7) 3.8 (3.6)
Refinement
Resolution (Å)a 36.39–1.21 (1.23–1.21) 30.798–1.76 (1.85–1.76) 42.51–2.03 (2.14–2.03)
Reflection, working 85213 18131 19628
Reflection, free 4468 927 968
Rwork/Rfree (%) 11.1/14.4 16.2/20.2 16.76/20.80
No of non-H atoms 2815 1264 2506
Protein A: 1185 B: 1185 1120 A: 1139 B: 1133
Others 45 (NAG) 16 (EDO) 56 (1,6-anhydro-disaccharide)
13 (Polypropylene glycol)
16 (DMSO)
Water 371 128 178
B factors (Å2)b 24.0 26.6 32.4
Protein A: 21.7 B: 21.6 25.5 A: 33.1 B: 31.2
Others 20.3 (NAG) 35.1 (EDO) 28.0 (1,6-anhydro-disaccharide)
44.5 (Polypropylene glycol)
64.6 (DMSO)
Water 37.0 35.05 36.839
Rmsds
Bond lengths (Å) 0.023 0.016 0.005
Bond angles (°) 2.2 1.495 0.990
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second 138 residue domain of MltA, YuiC just has a 10
residue loop linking the two sections of the barrel. All
the beta strands of YuiC have equivalents in MltA
(Fig. 1d). The first strand and adjacent peptide of YuiC
(84–96) is overlapped by the second and third strands of
the MltA (82–104), which has an eight residue loop be-
tween the two strands that does not superimpose with
YuiC. There is no equivalent of the first strand and helix
of MltA in YuiC. Where the CATH Barwin-like endo-
glucanase domain of MltA begins again (243–253), the
backbone is very close to YuiC (110–120) in a small
hairpin in both structures. The second to fifth strands of
YuiC superimpose with the tenth to thirteenth of YuiC.
Before the final strand of the beta barrel both have heli-
ces, which do not superimpose well. The YuiC helix at
this point, α3, is where the domain swap begins. The
final strand of the beta barrel (β6) is formed by the last
strand of YuiC from the other chain in the domain swap
and is equivalent to the last strand (β14) of MltA. YuiC
then has a pair of helices, which are close in space to
the helices at the N-terminus of MltA but are not struc-
turally equivalent.
Ligand binding
Crystallisation of YuiC in the presence of NAG gives a
structure with a single well defined NAG per chain. In-
cubation of YuiC with 5 mM penta-NAG in the crystal-
lisation results in two linked sugars in the final structure
per chain. One of the sugars is a NAG that occupies the
same −2 site as the sugar in the crystals grown in the pres-
ence of NAG monomer. The second sugar has clearly
formed a 1,6-anhydro reaction product. The interactions
of these compounds with YuiC are shown in Fig. 2a and b
and discussed more fully below. Peptidoglycan consists of
chains of alternating N-acetylglucosmine (NAG) and N-
acetylmuramic acid (NAM) sugars, cross-linked with pep-
tide chains. The two sugars differ at the O3 position,
where NAM has a lactate, which then links to the cross-
linking peptide, whereas NAG just has an OH. This means
that NAM is much more bulky at the O3 position, which
often confers the selectivity in cleavage.
The structure of the catalytically inactive D308A MltA
with chitohexose [20] (PDB 2pi8) has six clearly defined
NAG sugars, four, −4 to −1, on the non-reducing end
before the cleaved bond and two, +1 and +2, at the redu-
cing end. The NAG in + NAG superimposes with the −2
position in the chitohexose in MltA. The anhydro sugar
lies at the −1 position and the unmodified NAG lies at
the −2 position in the disaccharide reaction product.
The interaction of the conserved D297 (MltA)/D151
(YuiC) with the N of the N-acetyl group of the NAG at
the −2 position is conserved (Fig. 2a-c, Table 2). Further
hydrogen bonds to this sugar in YuiC are from the non-
conserved K102 NZ to the N-acetyl carbonyl and O3 of
NAG. MltA does not have any atoms near K102 NZ in
the superposition and K102 lies in the YuiC insert that
replaces a whole domain in MltA. The OH of S164 in
MltA does form an H bond to the −2 N-acetyl carbonyl,
but lies 4.2 Å from K102NZ in the superposition and
does not also interact with O3, and there is a water
(HOH 428) in the YuiC structure at the position of the
MltA S164 OH.
More generally there is good conservation of the back-
bone on the D151 side of the sugar, but little conserva-
tion on the other face. The O3 hydroxyl in the −2
position forms a hydrogen bond to the backbone carb-
oxyl of L111, which would prevent there being a N-
acetylmuramicacid (NAM) at this position. NAM can
easily be accommodated at the −1 position as the O3 of
the sugar, which has the lactic acid group in NAM and
then the peptide in peptidoglycan, is pointing into the
solvent. The −1 site in MltA has a hydrogen bond to the
main chain carboxyl of residue V298 from the O6 hy-
droxyl (Fig. 2c, Table 2). This backbone position is
Table 1 Data collection and refinement statistics (Continued)
Ramachandran plot
Favoured (%) 98.1 97.8 95.4
Allowed (%) 1.8 2.4 4.6
Outliers (%) 0 0 0
a Values in parentheses are for the highest-resolution shell
b Average over all atoms
Rmerge ¼
X
hkl
X
j
Ihkl;j− Ihklh ij jX
hkl
X
j
Ihkl;j
Rmeas ¼
X
hkl
ﬃﬃﬃﬃ
n
n−1
p Xn
j¼1 Ihkl;j− Ihklh ij jX
hkl
X
j
Ihkl;j
Rp:i:m ¼
X
hkl
ﬃﬃﬃﬃ
1
n−1
p Xn
j¼1 Ihkl;j− Ihklh ij jX
hkl
X
j
Ihkl;j
where Ihkl is the reflection intensity and < Ihkl > is the average intensity for multiple measurements of that reflection.
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conserved in YuiC, but the hydroxyl has moved away to
form the anhydro product and so this contact is lost in
the product. The N of the N-acetyl group is interacting
with the main chain carboxyl of V161 in MltA. This is
roughly equivalent in position to the carbonyl of S99 in
YuiC + anhydro structure, which forms a similar inter-
action, despite the overall fold not being conserved in
this region. The carbonyl oxygen of the acetyl group of
Fig. 1 Structure of YuiC and comparison with MltA. a Dimer of YuiC with NAG bound. Chain A is in magenta and Chain B in blue with the
positions of starts and ends of secondary structure elements labelled. NAG is ball and stick with carbon in green, oxygen in red and nitrogen in
blue. The distance between the CA of G176 of each chain is shown in Å. b Structural Superposition of YuiC structure backbones. +NAG chains in
magenta and blue with ligand in green, +Anhydro chains in red and pale crimson and ligand in dark purple. Apo chains in green and yellow.
c Structural superposition of + NAG YuiC in cyan (A72-176) and blue (B177-217) (pseudo monomer) and MltA from E.coli (PDB 2ae0) [19] in gold.
Lower picture is 90° rotation around horizontal of upper. The distance between A176 and B177 of YuiC is shown in Å. d Sequence alignment
based on the structural superposition in C with secondary structure elements labelled, conserved aspartates shown in green and other conserved
residues shown in red. G176, where the domain swap is centred, is coloured yellow and labelled. Structural superposition used SSM [36] in
CCP4MG [37], structural alignment generated by UCSF chimera [38], structures drawn with CCP4MG [37] and alignment with ESPRIPT [39]
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the −1 sugar in the YuiC + anhydro product interacts
with two main chain NH groups (S154 and A155), which
are conserved in MltA (G300 and A301), although the
carbonyl also interacts with the side chain OH of S154
in YuiC, which is an extra interaction compared to
MltA. In MltA the acetyl carbonyl is further away and
the interaction with G300/A301 is water mediated.
Without a product structure for MltA or an uncleaved
substrate in YuiC it is impossible to determine whether
the differences in binding are due to substrate/product
differences or protein differences.
The superposition of the MltA sugars allows us to look
more widely at possible sugar binding sites in YuiC. In-
triguingly there is only room for one sugar site on the
Fig. 2 Interactions with ligands for YuiC and MltA. a Interaction of YuiC (cyan) with NAG (green) (H bonds shown as black dotted lines and
non-carbon atoms O red and N blue). b Interaction of YuiC (yellow) with 1,6-anhydrodisaccharide (green). 2Fo-Fc electron density for the ligand at
1.0 sigma shown clipped to 1.5 Å around the ligand. c Interaction of MltA (magenta) with hexachitose (dark cyan) (PDB 2pi8) [20]. 2pi8 is a D308A
mutation to prevent catalysis so D308 (light crimson) from the superposed active MltA (PDB 2ae0) is shown [19]. a-c are superimposed views
d superposition of YuiC (yellow) with MltA (magenta) showing the superposition of substrates hexachitose (dark cyan) and the 1,6-anhydrodisaccharide
(green). This shows the ligands overlapping at the −1 and −2 sites. The sidechains of the three conserved aspartates giving rise to the 3D domain name
are also shown. e The potential clash of the ends of a hexachitose in the YuiC structure showing the +2 NAG of MltA (2pi8) clashing with chain B
domain swapping helix (dark crimson helix and transparent grey surface) and the −4 NAG clashing with a symmetry related copy of YuiC in the lattice
(dark green and transparent grey surface). Diagrams drawn with CCP4mg [37]
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vacant + side of the cleavage in the + NAG and anhydro
structure. The +2 sugar in the MltA superposition
clashes with the third (domain swap) helix backbone
(Fig. 2e). This would prevent the sugar chain being lon-
ger than +1 and so the dimer could only remove a ter-
minal NAG (ie be an exo glycosidase). However the
movement of the second pseudo monomer of the do-
main swapped dimer in the apo structure described
above, displaces the third helix away from this position
so that this clash is reduced to ends of side chains,
which could adopt other positions. This probably would
allow cleavage within a chain (endo) in the dimer as
well, and certainly allow removal of disaccharides as
seen in many lytic transglycosidases. In the pseudo
monomer, the block from the helix probably does not
occur and the active site is much more open so the
monomer is likely to be able to cleave in either an endo
or exo mode.
The main interactions with the +1 sugar in MltA are
formed by residues V161 and Q162, which lies in the
inserted domain in CATH that is not present in YuiC.
However, the hydroxyl of S99 of YuiC, which is part of
the much more direct link that replaces the inserted
domain, lies close to the position of the Q162 side
chain of MltA and could potentially hydrogen bond to
O3 of the +1 sugar. There is not much space round the
superimposed +1 O3 hydroxyl in YuiC and so the +1
position is likely to be specific to NAG and not able to
house a NAM residue.
Although we can only clearly see two sugars in the
product, potentially a third may be present in the anhy-
dro product in a disordered state. The regions of MltA
that interact with the −3 and −4 sugars in MltA are not
homologous with YuiC. The superimposed −4 sugar of
MltA collides with a symmetry related molecule of YuiC
(Fig. 2e) suggesting that a product with four sugars
would not bind in the lattice. Intriguingly this would be
the obvious product of the penta-NAG in the YuiC
dimer R3 crystal as the +2 position is also sterically
blocked. It is hard to envisage YuiC having any positive
interaction with a sugar in the −4 position as the protein
does not extend out that far. Despite being larger, MltA
only has limited interaction with the sugar at the −4
position. Careful inspection of the −3 site indicate some
waters are in positions likely to be where hydroxyls of the
sugar would be positioned, but if it is present the sugar is
either much more mobile or much less occupied due to
cleavage at a mixture of positions in the penta-NAG. It is
more likely that multiple cleavage events before crystals
formed have led to a predominant two sugar anhydro
product and this form bound to the dimer may have been
preferentially selected by the lattice.
Catalytic activity
The conserved aspartates of the 3D domain, the Pfam
annotation of YuiC (http://pfam.xfam.org/family/3D),
superimpose well with the equivalent residues in MltA.
YuiC D162 is equivalent to MltA D308 (A308 in 2pi8);
Table 2 List of Hydrogen bonds between protein and substrates and conservation in MltA
Sugar Site Ligand Atom +NAG (4wjt) +Anhydro (4wlk) MltA (2pi8) Conserved YuiC vs MltA
−2 O1 Thr152 O via HOH A550 None (O4 of −1) Gln162 O No. Thr100 YuiC is
closest to MltA Gln162
−2 O3 Leu111 O Leu111 O None No
−2 O3 Lys102 NZ Lys102 NZ No
−2 O4 HOH A430/435 None None
−2 O5 Thr100 O via HOH A531 HOH416 is too far (3.7 Å) None
−2 O6 Ser154 N and OG via HOH 539 None None
−2 O7 Lys102 NZ Lys102 NZ
−2 O7 Gly110 N and Ala 95 O
via HOH A489
Gly110 N and Ala 95 O
via HOH A428
Ser164 OG No. HOH 428 and Ser164
OG are close
−2 N2 Asp151 OD1 and OD2 Asp151 OD1 and OD2 Asp297 OD2 Yes. Asp151/297
−1 O1 Asp162 OD2 (O4 of +1) none but
Asp308 mutated to Ala
Yes. Asp162/308
−1 O3 None None
−1 O5 None None
−1 O6 Val298 O
−1 O7 Ser 154 N and OG Ala 155 N Gly300 N and Ala 301 N
via HOH A1045
Yes, but contact longer
via water in MltA
−1 N2 Ser99 O Val161 O No. Close in space
but not conserved
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YuiC D129 to MltA D261and YuiC D151 to MltA D297.
No equivalent atoms are further than 1.4 Å apart and all
CAs within 0.5 Å.
The conserved D162 is the catalytic carboxylate and is
orientated by T91 which is conserved in MltA (T99)
(Fig. 3). A number of proposed mechanisms for MltA
have been put forward. In the preferred mechanism of
Van Straaten et al. [20] the catalytic aspartate residue is
proposed to protonate the leaving hydroxyl at the +1
position and deprotonate the O6 hydroxyl, which attacks
a carbenium ion intermediate to form the anhydro prod-
uct. It is proposed in MltA that the carbenium ion is sta-
bilised by the α4 helix dipole. This helix lies in the
inserted domain which has no equivalent in YuiC. How-
ever in the + NAG and anhydro product structures the
nearest residues to the position of the helix in the super-
posed MltA are E98 and S99. The main chain carboxyl of
S99 is hydrogen bonding to the N of the N-acetyl group of
the −1 anhydrosugar with the side chain of E98 pointing
away towards the side chain of T94. However the stretch
of residues from 97 to 100 is disordered in the apo struc-
ture indicating that these residues are flexible and there-
fore E98 may be able to rearrange and act as a second
carboxylate in the reaction mechanism, either just to sta-
bilise the carbenium ion as the dipole is proposed to do in
MltA, or opening up the possibility of a two carboxylate
mechanism analogous to the retaining lysozymes.
Substrate assisted catalysis has also been proposed for
MltA [21]. This would require the −1 sugar N-acetyl
oxygen to be on the opposite face of the substrate from
Fig. 3 Schematic of the YuiC active site showing the conservation with MltA. The lower barrel side shows significant conservation to MltA
including the conserved catalytic aspartate and the residues allowing mechanism 2 of Powell et al. [21]. The upper face is not conserved.
Substrate assisted catalysis is unlikely because S154, which is unique to YuiC is holding the acetyl carbonyl in the wrong place for this
mechanism. The helix from MltA (purple) is thought to stabilise the carbenium ion. It is possible that the helix from YuiC (cyan) may play a similar
role or release E98 to act as a second carboxylate, as 97–100 are disordered in the apo structure indicating flexibility in this region. The two
helices are shown in their superimposed positions. Where two numbers are given the first is B.subtilis YuiC and the second E.coli MltA
(2pi8 numbering)
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the O6 that generates the anhydrosugar. However in
YuiC the −1 sugar N-acetyl group oxygen of the anhydro
product is interacting with S154 and is on the same face
as the O6 oxygen would be. Unless the S154 interaction
is only formed in the product then substrate assisted ca-
talysis using the N-acetyl group is unlikely, as a very
large rearrangement of the N-acetyl group is required to
place it in position to assist in substrate catalysis from
its position in the product structure. All the homologous
residues for the second mechanism of Powell et al. [21]
involving Y93 and D151 of YuiC acting in the same way
as proposed for Y140 and D393 of N. gonnorrhoeae
MltA to abstract the proton from the O6 to promote
nucleophilic attack on the carbenium to form the anhy-
dro product.
Is the monomer or the dimer the true structure?
Zymograms indicate that protein from both peaks of the
gel filtration are enzymatically active and can degrade pep-
tidoglycan after refolding after SDS-PAGE (Fig. 4a-b).
However, this does not demonstrate which oligomeric
states are active as the refolding from the unfolded mono-
mer in the gel could have led to either, or a mixture of
both, oligomeric states. A native gel shows no major dif-
ference in apparent size or activity of the samples originat-
ing from the monomer and dimer peaks (Fig. 4c-d),
probably the very high concentration in the stacking gel
has driven the protein largely into the dimer state. There
are some other higher oligomer bands that are also active,
particularly from the monomer peak.
The domain swapped dimer seen in the crystal may be
an artefact of high level expression in the E.coli cytosol
and high concentrations used for structural studies,
however, we have no direct evidence for this. Neverthe-
less, both the monomer and dimer are stable species.
Rerunning samples of either peak, after being frozen for
some weeks, gives a single peak with a similar retention
volume on gel filtration as when first run (Additional
file 1: Figure S1). This indicates that both states are
stable and there is at best very slow kinetic interchange
between the two.
It is pure speculation as to what the oligomeric state is
in B.sutbtilis in vivo. A mixture of the two states is pos-
sible, particularly as both are kinetically stable and prob-
ably active. Highly expressing protein in the cytoplasm
of E.coli is different from an unknown level of expres-
sion of secreted protein in B.subtilis, so the distribution
seen in our experiments may not reflect nature. Further-
more YuiC may interact with the cell wall or other en-
zymes through the disordered region at the N-terminus,
which could influence its ability to oligomerise. Peptido-
glycan remodelling enzymes are known to interact. RpfB
and RpfE bind to RipA and there is synergy in cleavage
seen between the two [22–24]. Indeed RpfB and RipA
assemble into a larger complex with PBP1 at the poles
septum [24]. The assembly of multiple peptidoglycan en-
zymes is a theme also seen in Gram-negative E. coli [25].
Conclusions
The structure of YuiC from B. subtilis has shown that
the stationary phase survival (Sps) proteins are smaller
versions of the MltA family of lytic transglycosylases.
This structural simplification is analogous to that of the
resuscitation promoting factors in Actinobacteria being
reduced versions of lysozyme and Slt proteins [7]. In-
deed there is conservation of ancillary domains between
groupings of the Rpfs and the Sps and in some cases
synteny in the surrounding operons [14].
Our structural work has shown that the Sps protein
family is indeed homologous to MltA, but a more com-
pact, perhaps minimal, version of the enzyme. We have
also trapped an 1,6-anhydrosugar product in the active
site, showing that formation of a 1,6-anhydrosaccharide
is the product of the reaction. The analogy with the re-
suscitation promoting factors of Actinomycetes supports
the role of these proteins in stationary phase survival of
the Firmicutes.
Methods
Protein cloning, expression and purification
Full-length mature protein K32-E218 (Uniprot YUIC_-
BACSU residues 32–218) was cloned into vector pET151/
TOPO (Novagen, Merck Millipore) with a Tobacco Etch
Virus (TEV) Protease cleavable His-Tag. This vector re-
sults in GIDPFT on the N-terminus after the TEV prote-
ase cleavage. Truncated (R52-K217, R52-E218, P73-E218,
P73-K217) YuiC proteins were cloned into pNic28-Bsa4
plasmid (supplied by Dr Opher Gileadi of the Structural
Genomics Consortium), which is a modified pET28a plas-
mid that allows ligation independent cloning [26] and only
adds a single serine to the N terminus after TEV cleavage.
Proteins were expressed in E. coli Rosetta 2 (DE3)
(Novagen, Merck Millipore) using Terrific Broth by in-
duction with 0.25 mM IPTG at 30 °C for 6 h after the
culture had reached A600 of 0.6. The cells were har-
vested and resuspended in lysis buffer containing 0.1 M
Tris–HCl pH 7.0, 0.5 M NaCl, 50 mM Imidazole, 2 mM
βME, 2 mg/mL lysozyme and a cOmplete EDTA-free pro-
tease inhibitor cocktail tablet (Roche Applied Science,
Switzerland). The cell suspension was sonicated on ice at
20 Watts for 4 min twice using 5 s interval pulses and the
sample was treated with DNaseI for 30 min. The sample
was then centrifuged at 48,000 × g for 60 min at 4 °C to
obtain the supernatant. The protein supernatant was
loaded onto a 5 mL HisTrap FF (GE healthcare, USA) col-
umn using a peristaltic pump, washed with 10 column vol-
umes of binding buffer (0.1 M Tris–HCl pH 7.0, 0.5 M
NaCl, 50 mM Imidazole, 2 mM βME) and the his-tagged
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YuiC protein was collected in the elution buffer (0.1 M
Tris–HCl pH 7.0, 0.5 M NaCl, 500 mM Imidazole, 2 mM
βME). The protein sample was then incubated with TEV
protease (1 mg/mL) and dialysed against 4 L buffer con-
taining 20 mM Tris–HCl, pH 7.5 and 2 mM βME at 4 °C
overnight. The protein was passed through a HisTrapFF
column to collect untagged YuiC protein.
The proteins were further purified by ion exchange
and gel filtration, the conditions used varied for each
construct. For full-length protein, the sample was dia-
lysed again using 20 mM Tris–HCl pH 8.4 prior to
anion exchange chromatography. A Resource Q column
(1 mL) was pre-equilibrated with buffer containing
20 mM Tris–HCl, pH 8.4, 2 mM βME before protein
Fig. 4 Zymograms of YuiC. a SDS-PAGE and b denaturing zymogram of YuiC_P73 and YuiC_R52 constructs. Lane 1: YuiC_P73-E218 dimer, 2:
YuiC_P73-E218 monomer, 3: YuiC_P73-K217 dimer, 4: YuiC_P73-K217 monomer, M: PageRuler prestained protein ladder, 5: YuiC_R52-E218 peak 1
(monomer), 6: YuiC_R52-E218 peak 2 (dimer), 7: YuiC_R52-E218 peak 3 (oligomers), 8: YuiC_R52-K217 peak 1 (monomer), 9: YuiC_R52-K217 peak 2
(dimer), 10: YuiC_R52-K217 (oligomers). c Native-PAGE and d native zymogram of YuiC_P73 constructs. Lane 1: Lysozyme, M: NativeMark unstained
protein standard, 2: YuiC_P73-E218 dimer, 3: YuiC_P73-E218 monomer, 4: YuiC_P73-K217 dimer, 5: YuiC_P73-K217 monomer, 6: negative control
(Rv3368). Positions of the principal bands in the native zymogram are marked with red arrows as they are faint
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loading and gradient of 20 Column Volumes to 100 % of
buffer containing 20 mM Tris–HCl pH 8.4, 1 M NaCl,
2 mM βME was used for protein elution. To further
purify the protein, size exclusion chromatography was
carried out using a HiLoad Superdex 200 column pre-
equilibrated with 20 mM Tris–HCl pH 8.0, 50 mM
NaCl, 2 mM βME buffer. For YuiC P73-E218 and YuiC
P73-K217, the anion exchange chromatography used
20 mM Bis-tris pH 7.0, 2 mM βME for the binding buf-
fer and 20 mM Bis-tris pH 7.0, 2 mM βME, 1 M NaCl
for the elution buffer. For size exclusion chromatog-
raphy, 20 mM Bis-tris pH7.0, 150 mM NaCl and 2 mM
βME buffer was used. For YuiC R52-E218 and YuiC
R52-K217, cation exchange chromatography was carried
out using an SP HP (GE Healthcare) column. For YuiC
R52-E218 protein, the binding buffer used was 50 mM
MES pH 6.5, 2 mM βME and for the elution buffer,
50 mM MES pH 6.5, 1 M NaCl, 2 mM βME elution buf-
fer. Whereas for YuiC R52-K217 protein, 50 mM HEPES
pH 7.5, 2 mM βME was used as the binding buffer and
50 mM HEPES pH 7.5, 1 M NaCl, 2 mM βME as the
elution buffer. Size exclusion chromatography for YuiC
R52-E218 protein was carried out in 50 mM MES
pH 6.5, 100 mM NaCl, 2 mM βME buffer.
Zymograms
The 15 % SDS-PAGE zymogram gel was prepared by the
addition of 0.2 % (w/v) lyophilised M. luteus cells to a
standard 15 % SDS-PAGE resolving gel. Protein samples
(1.57 mM) were mixed with 4× SDS sample buffer with-
out βME and were not heated before loading. The gel
was run at 180 V for an hour. After electrophoresis, to
remove SDS the gel was rinsed three times by shaking
gently in 100 mL of distilled water for 20 min. The gel
was then rinsed with 100 ml of renaturation buffer
(50 mM sodium phosphate, pH 5.0) for 30 min and then
changed to fresh renaturation buffer (100 mL) for over-
night digestion at room temperature. Triton X-100 (1 %)
was added to all of the renaturation buffers to keep pro-
tein from aggregation. The zymogram was stained with
0.1 % methylene blue in 0.01 % potassium hydroxide
and destained with distilled water until a clear band
could be seen against the blue background. For the na-
tive PAGE zymogram, both the gel and protein samples
(1.57 mM) were prepared without any reducing or de-
naturing agents (SDS, βME) and were not heated prior
to gel loading. 0.2 % (w/v) M. luteus lyophilised cells was
added to the 10 % separating gel. After electrophoresis,
the gel was incubated with buffer containing 20 mM
Tris–HCl pH 7.0, 150 mM NaCl and 2 mM βME for
overnight digestion. The gel was stained and destained
as described for the denaturing zymogram. Lysozyme
was used as positive control, whereas a nitroreductase
from Mtb, Rv3368, was used as the negative control.
Crystallisation
YuiC at concentrations of 12–16 mg/mL was used to set
up crystallisation trials by sitting drop vapour diffusion
set up with a Mosquito robot. The monomer and dimer
peaks from gel filtration were always concentrated and
used separately. Crystals were only obtained from dimer
peak samples. The MIDAS screen [27] proved particu-
larly useful in identifying conditions. The crystallisation
and cryoprotection conditions of the reported structures
are Apo: YuiC (P73-E218) (0.2 M ammonium chloride,
25 % (v/v) glycerol ethoxylate, 0.1 M HEPES pH 7.5; cryo-
protectant: 20 % ethylene glycol), +NAG: YuiC (degraded
K32-E218) with 5 mM NAG (48 % (v/v) polypropylene
glycol P400, 0.1 M HEPES pH 6.0, 3 % (v/v) DMSO; no
cryoprotectant required) and + Anhydro: YuiC (R52-K217)
with 5 mM penta-NAG (penta-N-acetyl-chitopentaose,
Seikagaku Corporation Japan) (40 % glycerol ethoxylate;
cryoprotectant: 20 % ethylene glycol).
Structure solution and refinement
A dataset of a crystal of YuiC grown in the presence of
NAG was collected at Diamond Synchrotron beam line
I02 in space group R3, with two chains predicted in the
asymmetric unit. The structure was not readily solved by
molecular replacement. A large number of models were
generated based on the remote homology to MltA using
a variety of structure prediction websites and hand trun-
cation and a range of molecular replacement packages.
Eventually a solution was found using ACORN [28], a
programme designed for ab initio phasing, using a start-
ing model based on PDB 2ae0, the structure of E. coli
MltA [19]. The model was generated by the Phenix
MR_Rosetta protocol [29] using an HHPred [30] derived
alignment. However, this model did not give a convin-
cingly buildable solution on the default settings in phe-
nix MR_Rosetta. A rebuild of the ACORN map with
Arp/wARP [31] gave a virtually complete model, which
was further improved by cycles of rebuilding in coot [32]
and refinement with Refmac5 [33]. The subsequent apo
and + anhydro structures were solved by molecular re-
placement from the + NAG structure with phaser [34]
and refinement with Refmac5 and phenix.refine [35] re-
spectively. Residues 72–217 in both chains are modelled
in + NAG, 72–216 in chain A and 73–216 in chain B of
+ anhhydro and 73–214, missing 97–100 inclusive, in
the single chain of the apo structure.
Availability of supporting data
The structures and structure factors are deposited in
the RCSB Protein Data Bank as entries 4WJT (+NAG)
http://www.rcsb.org/pdb/search/structidSearch.do?str
uctureId=4wjt, 4WLI (Apo) http://www.rcsb.org/pdb/
search/structidSearch.do?structureId=4wli and 4WLK (+a
nhydro) http://www.rcsb.org/pdb/search/structidSearch.do?
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structureId=4wlk. Additional figures are in a file supple-
mentaryquayyuic2.pdf in PDF (Portable Document For-
mat). It contains three figures and legends describing
characterisation of oligomeric state by gel filtration,
degradation of the full-length protein and NMR spectra
showing loss of unfolded regions on degradation.
Additional file
Additional file 1: Figure S1. Size exclusion chromatography molecular
weight estimation of YuiC constructs. Figure S2. SDS-PAGE profile shows
partial protein truncation of YuiC K32-E218. Figure S3. 1D NMR profiles
of YuiC K32-E218.
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